N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine

C101H147N15O5 — CID 159993852

IUPACN-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine
SMILESCCC(CC)Nc1cc(-c2nc(C)no2)ccc1CC1CCCCC1.COc1cnc(CC2CCCCC2)c(NC2CCCCC2)c1.Cc1coc(-c2cnc(CC3CCCCC3)c(NC3CCCCC3)c2)n1.Cc1noc(-c2ccc(CC3CCCCC3)c(NC3CCCC3)c2)n1.Cc1noc(-c2cnc(CC3CCCCC3)c(NC(C)C)c2)n1
InChIInChI=1S/C22H31N3O.C21H29N3O.C21H31N3O.C19H30N2O.C18H26N4O/c1-16-15-26-22(24-16)18-13-21(25-19-10-6-3-7-11-19)20(23-14-18)12-17-8-4-2-5-9-17;1-15-22-21(25-24-15)18-12-11-17(13-16-7-3-2-4-8-16)20(14-18)23-19-9-5-6-10-19;1-4-19(5-2)23-20-14-18(21-22-15(3)24-25-21)12-11-17(20)13-16-9-7-6-8-10-16;1-22-17-13-19(21-16-10-6-3-7-11-16)18(20-14-17)12-15-8-4-2-5-9-15;1-12(2)20-17-10-15(18-21-13(3)22-23-18)11-19-16(17)9-14-7-5-4-6-8-14/h13-15,17,19,25H,2-12H2,1H3;11-12,14,16,19,23H,2-10,13H2,1H3;11-12,14,16,19,23H,4-10,13H2,1-3H3;13-16,21H,2-12H2,1H3;10-12,14,20H,4-9H2,1-3H3
InChIKeyOHHGFLKEZWSHAC-UHFFFAOYSA-N
MW1651.39 g/mol
LogP26.54
Rot. Bonds27

About N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine

N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine (PubChem CID 159993852) has the molecular formula C101H147N15O5 and a molecular weight of 1651.39 g/mol. Its IUPAC name is N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine.

Molecular Properties

Compound NameN-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine
PubChem CID159993852
Molecular FormulaC101H147N15O5
Molecular Weight1651.39 g/mol
Exact Mass1650.17
IUPAC NameN-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine
SMILESCCC(CC)Nc1cc(-c2nc(C)no2)ccc1CC1CCCCC1.COc1cnc(CC2CCCCC2)c(NC2CCCCC2)c1.Cc1coc(-c2cnc(CC3CCCCC3)c(NC3CCCCC3)c2)n1.Cc1noc(-c2ccc(CC3CCCCC3)c(NC3CCCC3)c2)n1.Cc1noc(-c2cnc(CC3CCCCC3)c(NC(C)C)c2)n1
InChIInChI=1S/C22H31N3O.C21H29N3O.C21H31N3O.C19H30N2O.C18H26N4O/c1-16-15-26-22(24-16)18-13-21(25-19-10-6-3-7-11-19)20(23-14-18)12-17-8-4-2-5-9-17;1-15-22-21(25-24-15)18-12-11-17(13-16-7-3-2-4-8-16)20(14-18)23-19-9-5-6-10-19;1-4-19(5-2)23-20-14-18(21-22-15(3)24-25-21)12-11-17(20)13-16-9-7-6-8-10-16;1-22-17-13-19(21-16-10-6-3-7-11-16)18(20-14-17)12-15-8-4-2-5-9-15;1-12(2)20-17-10-15(18-21-13(3)22-23-18)11-19-16(17)9-14-7-5-4-6-8-14/h13-15,17,19,25H,2-12H2,1H3;11-12,14,16,19,23H,2-10,13H2,1H3;11-12,14,16,19,23H,4-10,13H2,1-3H3;13-16,21H,2-12H2,1H3;10-12,14,20H,4-9H2,1-3H3
InChIKeyOHHGFLKEZWSHAC-UHFFFAOYSA-N
XLogP26.54
TPSA250.84 Ų
H-Bond Donors5
H-Bond Acceptors20
Rotatable Bonds27
Heavy Atoms121
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001651.39
LogP ≤ 526.54
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1020

Analyze N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

12-[(4,4-difluoropiperidin-1-yl)methyl]-4-(1H-indol-4-yl)-6-morpholin-4-yl-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;12-[(4-fluoropiperidin-1-yl)methyl]-4-(1H-indol-4-yl)-6-morpholin-4-yl-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;4-(1H-indol-4-yl)-6,12-dimorpholin-4-yl-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;4-(1H-indol-4-yl)-11-methyl-6-morpholin-4-yl-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene
CID 158180516
6-[2-(Cyclopenten-1-yl)ethynyl]-8-[2-(dimethylamino)ethyl]-2-(4-piperidin-4-yloxyanilino)pyrido[2,3-d]pyrimidin-7-one;6-(2-cyclopentylethynyl)-2-[4-(1-methylpyrrolidin-3-yl)oxyanilino]-8-[(5-phenyl-1,3-oxazol-4-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;8-[(5-cyclopentyl-1,2-oxazol-4-yl)methyl]-6-(2-ethoxyethynyl)-2-(4-piperidin-3-yloxyanilino)pyrido[2,3-d]pyrimidin-7-one;6-(3-methylbut-1-ynyl)-2-[4-(4-methylmorpholin-2-yl)anilino]-8-[[1-(trifluoromethyl)imidazol-2-yl]methyl]pyrido[2,3-d]pyrimidin-7-one
CID 161476673
2-[6-benzo[h]quinolin-2-yl-7-(furan-2-yl)-5-(1H-imidazol-2-yl)-4-isoquinolin-1-yl-2-(1,2-oxazol-3-yl)-1H-indol-3-yl]-1,3-oxazole
CID 141106718
1-[6-(4,5-dihydroimidazol-1-yl)-2-(1,8-naphthyridin-2-yl)-4-(1,2-oxazol-3-yl)-7-(1,3-oxazol-2-yl)-3-quinolin-2-ylphenanthridin-1-yl]-10H-phenoxazine
CID 141300030
2-[2-(4-fluorophenyl)-1,3-oxazol-4-yl]propan-1-amine;N-[2-[2-(4-fluorophenyl)-1,3-oxazol-4-yl]propyl]-5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxamide;5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxylic acid
CID 157061987
cumene;bis(5-cyclobutyl-3-methyl-1,2,4-oxadiazole);bis(5-cyclohexyl-3-methyl-1,2,4-oxadiazole);5-(2,3-dihydro-1H-inden-5-yl)-3-methyl-1,2,4-oxadiazole;methane;3-(3-methyl-1,2,4-oxadiazol-5-yl)cyclohexan-1-one;bis(2-methyl-5-phenyl-1,3,4-oxadiazole);3-methyl-5-phenyl-1,2,4-oxadiazole;5-methyl-3-phenyl-1,2,4-oxadiazole;3-methyl-5-phenyl-1,2-oxazole;4-methyl-2-phenyl-1,3-oxazole;1-methyl-4-phenylpiperidine;4-methyl-1-phenyltriazole;3-methyl-5-pyridin-3-yl-1,2,4-oxadiazole;3-methyl-5-pyrrolidin-3-yl-1,2,4-oxadiazole;1-phenylethanone;propylbenzene
CID 157091264
N-[3-[(2-hydroxy-4-methylphenyl)methylamino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-[(3-hydroxy-4-methylphenyl)methylamino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-(1H-indol-3-ylmethylamino)propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-[(5-methoxy-3-pyridinyl)methylamino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-[(4-methylfuran-2-yl)methylamino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-[(2-methyl-1,3-oxazol-5-yl)methylamino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-[(5-methyl-2-pyridinyl)amino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;5-phenyl-N-[3-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylamino)propyl]-1,2-oxazole-3-carboxamide
CID 157267222
7-methoxy-1-[3-[4-(2-methoxyphenyl)piperidin-1-yl]propyl]-N-(2-methylpropyl)indole-3-carboxamide;7-methoxy-N-(2-methylpropyl)-1-[3-[4-(2-phenoxyethyl)piperazin-1-yl]propyl]indole-3-carboxamide;7-methoxy-N-(2-methylpropyl)-1-[3-[4-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]propyl]indole-3-carboxamide
CID 157598686
5-(1,3-Benzoxazol-2-yl)-2-(oxan-4-ylmethyl)aniline;2-[1-(oxan-4-yl)-2-pyridin-3-ylbenzimidazol-5-yl]-1,3-benzoxazole
CID 157775477
N,N-dimethyl-3-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)aniline;5-[3-(furan-2-yl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;N-methyl-3-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)aniline;5-[3-(1,3-oxazol-4-yl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;3-pyridin-4-yl-5-(3-pyrrolidin-1-ylphenyl)-1,2,4-oxadiazole;3-pyridin-4-yl-5-(4-pyrrolidin-1-ylphenyl)-1,2,4-oxadiazole
CID 157843586
4-[4-(2-aminoethyl)-1,3-oxazol-2-yl]benzonitrile;N-[2-[2-(4-cyanophenyl)-1,3-oxazol-4-yl]ethyl]-5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxamide;5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxylic acid
CID 157887807
1-(3-amino-4-deca-3,5-diynylphenyl)-4-piperidin-1-ylbutan-1-one;tert-butyl 5-(cyclohexylamino)-6-(cyclohexylmethyl)pyridine-3-carboxylate;N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)-N-propan-2-ylaniline
CID 157941843

Frequently Asked Questions

What is the IUPAC name of N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine?
The IUPAC name of N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine (CID 159993852) is N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine.
What is the SMILES notation for N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine?
The canonical SMILES for N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine is CCC(CC)Nc1cc(-c2nc(C)no2)ccc1CC1CCCCC1.COc1cnc(CC2CCCCC2)c(NC2CCCCC2)c1.Cc1coc(-c2cnc(CC3CCCCC3)c(NC3CCCCC3)c2)n1.Cc1noc(-c2ccc(CC3CCCCC3)c(NC3CCCC3)c2)n1.Cc1noc(-c2cnc(CC3CCCCC3)c(NC(C)C)c2)n1.
What is the InChIKey of N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine?
The InChIKey is OHHGFLKEZWSHAC-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H31N3O.C21H29N3O.C21H31N3O.C19H30N2O.C18H26N4O/c1-16-15-26-22(24-16)18-13-21(25-19-10-6-3-7-11-19)20(23-14-18)12-17-8-4-2-5-9-17;1-15-22-21(25-24-15)18-12-11-17(13-16-7-3-2-4-8-16)20(14-18)23-19-9-5-6-10-19;1-4-19(5-2)23-20-14-18(21-22-15(3)24-25-21)12-11-17(20)13-16-9-7-6-8-10-16;1-22-17-13-19(21-16-10-6-3-7-11-16)18(20-14-17)12-15-8-4-2-5-9-15;1-12(2)20-17-10-15(18-21-13(3)22-23-18)11-19-16(17)9-14-7-5-4-6-8-14/h13-15,17,19,25H,2-12H2,1H3;11-12,14,16,19,23H,2-10,13H2,1H3;11-12,14,16,19,23H,4-10,13H2,1-3H3;13-16,21H,2-12H2,1H3;10-12,14,20H,4-9H2,1-3H3.
What are the key properties of N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine?
N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine has a molecular weight of 1651.39 g/mol, XLogP of 26.54, 27 rotatable bonds, 5 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine is sourced from PubChem (CID 159993852), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).